| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 07/26/2005 | US6921636 Method and apparatus for conducting an array of chemical reactions on a support surface |
| 07/22/2005 | CA2455659A1 Barhl2 proteins, genes encoding the same and uses thereof |
| 07/21/2005 | WO2005066363A2 Cancer specific gene ccndbp1 |
| 07/21/2005 | WO2005066361A1 Method for enriching and stabilising components which contain dna and which are made of biological materials |
| 07/21/2005 | WO2005066334A1 Phosphokinase and the usage thereof |
| 07/21/2005 | WO2005065418A2 Compositions and methods of use of targeting peptides for diagnosis and therapy |
| 07/21/2005 | WO2005065405A1 Membranes incorporating recognition moieties |
| 07/21/2005 | WO2005065384A2 Electronic trading data integration and protection system |
| 07/21/2005 | WO2005065328A2 Macrophage migration inhibitory factor (mif) as marker for urological inflammatory disease |
| 07/21/2005 | WO2005065309A2 Lentiviral vector delivery of native and mutated igfbp-3 for treatment of cancer |
| 07/21/2005 | WO2005065290A2 Metallization of nucleic acids by metal sols, and uses thereof |
| 07/21/2005 | WO2005065268A2 Oligonucleotide compound and method for treating nidovirus infections |
| 07/21/2005 | WO2005065239A2 Novel recombinant proteins with n-terminal free thiol |
| 07/21/2005 | WO2005047470A3 Intercalator fret donors or acceptors |
| 07/21/2005 | WO2005046459A3 Primers, methods and kits for detecting killer-cell immunoglobulin-like receptor alleles |
| 07/21/2005 | WO2005042018A3 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 07/21/2005 | WO2005040399A3 Methods for quantitative determination of methylation density in a dna locus |
| 07/21/2005 | WO2005040186A3 Method for preparing a modified host cell |
| 07/21/2005 | WO2005037226A3 Genetically engineered enteroendocrine cells for treating glucose-related metabolic disorders |
| 07/21/2005 | WO2005012351A3 Novel functions for decay accelerating factor (daf) in inflammation |
| 07/21/2005 | WO2004024064A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | WO2003085095A3 Novel expressed genes |
| 07/21/2005 | WO2003078573A8 Toll-like receptor 11 |
| 07/21/2005 | US20050160499 Vernalization-related molecules and methods for inducibly-conferring epigenetic changes |
| 07/21/2005 | US20050160498 Controlling flowering in plants via gene expression inhibition of cysteine proteases |
| 07/21/2005 | US20050159591 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | US20050159590 Variants of interleukin-1 receptor antagonist: compositions and uses thereof |
| 07/21/2005 | US20050159588 Nucleotide sequences coding tumor-associated antigenic target polypeptides; diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 07/21/2005 | US20050159392 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |
| 07/21/2005 | US20050159384 Human RNase III and compositions and uses thereof |
| 07/21/2005 | US20050159380 used to modulate the expression of Angiopoietin genes |
| 07/21/2005 | US20050159379 RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA) |
| 07/21/2005 | US20050159375 Novel oligonucleotides and related compounds |
| 07/21/2005 | US20050159374 Gene expression inhibition; for treatment of tumors, cancer |
| 07/21/2005 | US20050158838 Novel enterokinase cleavage sequences |
| 07/21/2005 | US20050158830 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/21/2005 | US20050158829 Fusion polypeptides capable of activating receptors |
| 07/21/2005 | US20050158822 Expresion vector comprising nucleotide sequences coding secreted glycoprotein hormone with modified untranslated region for use in enhancement of blood production; directed protein evolution |
| 07/21/2005 | US20050158819 Preparing wafer substrate with immobilized probes, separating into individual chips, mating chips to package associated with reaction chamber; high throughput assay |
| 07/21/2005 | US20050158811 Using ras palmitoyltransferase as tool in identifying modulators for treatment and prevention of liver disorders |
| 07/21/2005 | US20050158799 TRIF-related adaptor molecule (TRAM) and uses thereof |
| 07/21/2005 | US20050158786 Expression vector comprising nucleotide sequences coding membrane receptor for use in identifying modulator for prevention and treatment of metabolic disorders; hormone replacement therapy |
| 07/21/2005 | US20050158783 Reagent for the isolation of RNA |
| 07/21/2005 | US20050158774 Expression vector comprising plant seed coat promoter for use as tool in enhancement of transcription of heterologous gene expression sequences; bioreactors |
| 07/21/2005 | US20050158772 Nucleic acid analysis techniques |
| 07/21/2005 | US20050158770 Microwave mediated synthesis of nucleic acid probes |
| 07/21/2005 | US20050158768 Reagents and methods for detecting Neisseria gonorrhoeae |
| 07/21/2005 | US20050158765 Solid phase synthesis |
| 07/21/2005 | US20050158754 Nucleotide sequences coding testis specific-protein y-like (TSPYL) genes for use in identifying modulator for treatment and prevention of sudden infant death with dysgenesis of the testes syndrome (SIDDT) |
| 07/21/2005 | US20050158750 Expression vector comprising nucleotide sequences coding interleukin specific immunoglobulin for use in regulating activation, development, differentiation and function of hematopoietic cells |
| 07/21/2005 | US20050158747 Gene therapy; microarrays |
| 07/21/2005 | US20050158744 Microarray comprising preferential oligonucleotides for use in drug screening and disease diagnosis |
| 07/21/2005 | US20050158743 Arrays for detecting nucleic acids |
| 07/21/2005 | US20050158740 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
| 07/21/2005 | US20050158739 Using methylation status/profile of gene sequences as diagnostic tool in detection of cell proliferative disorders |
| 07/21/2005 | US20050158727 Derivatized oligonucleotides having improved uptake and other properties |
| 07/21/2005 | US20050158725 Method of amplifying nucleic acid by electromagnetic induction heating and reaction container and reaction device to be used therein |
| 07/21/2005 | US20050158720 Tripartite molecular beacons |
| 07/21/2005 | US20050158716 Nucleic acid detection kits |
| 07/21/2005 | US20050158712 Methods for purifying viral particles for gene therapy |
| 07/21/2005 | US20050158711 viral vector containing a polynucleotide sequence contains two different affinity tag sequences, one of the two affinity tag sequences encodes streptavidin-binding peptide and other encodes calmodulin binding peptide |
| 07/21/2005 | US20050158710 Oligonucleotide primers and/or hybridization probes for use as diagnostic tools in detecting picornavirus infection; diagnosing gastrointestinal disorders |
| 07/21/2005 | US20050158707 Full - length genomic RNA of papaya leaf - distortion mosaic virus |
| 07/21/2005 | US20050158344 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 07/21/2005 | US20050158343 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 07/21/2005 | US20050158335 Polynucleotides from a gene cluster encoding pilin polypeptides; treating or immunizing against infections such as otitis media; antibodies, assays |
| 07/21/2005 | US20050158332 MHC-Class II restricted melanoma antigens and their use in therapeutic methods |
| 07/21/2005 | US20050158327 Interrupting the interaction of intercellular adhesion molecule-1 and respiratory syncytial virus for prevention and treatment of infection |
| 07/21/2005 | US20050158323 Via antibodies specific for antigen C35; host cells |
| 07/21/2005 | US20050158309 Gonadotropin-releasing hormone (gnrh); gene expression inhibition; for treatment of T-cell related neoplastic diseases |
| 07/21/2005 | US20050158295 Modified plasminogen inhibitor type-1 and methods based thereon |
| 07/21/2005 | DE102004059710A1 Preparing a biological sample containing DNA for automatic isolation comprising concentrating and stabilizing in a lysis bonding buffer system without using large samples or centrifuges |
| 07/21/2005 | DE102004045139A1 Dendrimer-basierte DNA-Extraktionsverfahren und Biochips Dendrimer-based DNA extraction procedure and biochips |
| 07/21/2005 | CA2552010A1 Method for enriching and stabilising components which contain dna and which are made of biological materials |
| 07/21/2005 | CA2552007A1 Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids |
| 07/21/2005 | CA2551812A1 Electronic trading data integration and protection system |
| 07/21/2005 | CA2551131A1 Novel recombinant proteins with n-terminal free thiol |
| 07/21/2005 | CA2550854A1 Membranes incorporating recognition moieties |
| 07/21/2005 | CA2550642A1 Oligonucleotide compound and method for treating nidovirus infections |
| 07/20/2005 | EP1555319A2 Modified nucleic acid sequences and method to increasing mRNA levels and protein expression in cell systems |
| 07/20/2005 | EP1554405A1 Compositions, methods, and kits relating to behab and primary cns tumors |
| 07/20/2005 | EP1554398A2 Apparatus and method for preparative scale purification of nucleic acids |
| 07/20/2005 | EP1554381A2 Post transcriptional silencing by short interfering rnas |
| 07/20/2005 | EP1554377A2 Thermostable reverse transcriptases and uses thereof |
| 07/20/2005 | EP1554302A2 Methods and dna constructs for high yield production of polypeptides |
| 07/20/2005 | EP1554301A2 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 |
| 07/20/2005 | EP1553978A2 Interacting site for gp41 on gp120 of hiv-1 |
| 07/20/2005 | EP1553976A2 Hiv envelope-cd4 complexes and hybrids |
| 07/20/2005 | EP1421095A4 Assay for detection of human parvovirus b19 nucleic acid |
| 07/20/2005 | EP1153931B1 Shortened-chain polynucleotides and process for the preparation thereof |
| 07/20/2005 | EP1141718B1 Coupling of lipopolysaccharide-derived carbohydrates onto solid surfaces |
| 07/20/2005 | CN1643145A Purification methods for oligonucleotides and their analogs |
| 07/20/2005 | CN1643142A Method of identifying genes controlling diferentiation |
| 07/20/2005 | CN1641030A Gene encoding cysteine protease and its promoter and method for producing male sterile rice |
| 07/20/2005 | CN1640891A Epinephelus anti-transgenosis protein and nucleotide sequence and use thereof |
| 07/20/2005 | CN1640890A Cell withering factor derivated from placents |
| 07/20/2005 | CN1640884A Foot and mouth disease virus infectious complementary deoxyribonucleic acid and its preparation method |
| 07/20/2005 | CN1211123C Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 07/19/2005 | US6919445 Detecting with a multicolor fluorescent dyes, for automated 4-DNA sequencing systems, identifying the classes of the polynucleotides |
| 07/19/2005 | US6919441 Used as inhibitors of gene expression (antisense oligonucleotides, ribozymes, sense oligonucleotides and triplex forming oligonucleotides), as probes for detecting nucleic acids and as aids in molecular biology |